Elizabeth Garrett-Mayer to Receptor, ErbB-2
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Receptor, ErbB-2.
Connection Strength
0.176
-
A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer. Cancer Immunol Res. 2014 Oct; 2(10):949-61.
Score: 0.107
-
HER-2/neu-specific monoclonal antibodies collaborate with HER-2/neu-targeted granulocyte macrophage colony-stimulating factor secreting whole cell vaccination to augment CD8+ T cell effector function and tumor-free survival in Her-2/neu-transgenic mice. J Immunol. 2003 Aug 15; 171(4):2161-9.
Score: 0.050
-
Racial differences in the incidence of breast cancer subtypes defined by combined histologic grade and hormone receptor status. Cancer Causes Control. 2010 Mar; 21(3):399-409.
Score: 0.019